Procurement Summary
Country : USA
Summary : Radio Frequency Therapy System for WACH
Deadline : 22 Jul 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 122910405
Document Ref. No. : W81K0025QA150
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Description
Clinical Efficacy and Performance.
Ablation Success Rates: Documented amenorrhea rates (e.g., 50-60%) and a significant reduction in bleeding (e.g., 90% patient satisfaction) at 12 months post-procedure from clinical trials or post-market surveillance.
Treatment Time: Short, standardized procedure time (e.g., typically
Uterine Cavity Compatibility: Stated range of uterine lengths (e.g., 6-10 cm, or 8-12 cm) and fundal width accommodation (e.g., by expandable array). Ensures applicability to a broad range of patients without requiring multiple specialized probes, reducing inventory and ensuring more patients are eligible (e.g., 4-6mm) across the entire endometrial surface, including cornual regions, as confirmed by histology or follow-up. Importance: reduced risk of incomplete alation, persistent bleeding, and need for repeat procedure.
End-point Detection: Automatic system shut-off based on reaching specific internal parameters (e.g., impedance rise, temperature plateau, complete energy delivery) that indicate successful ablation. Endures consistent, complete ablation while preventing overtreatment and relies less on user judgment, improving consistency across multiple gynecologists.
Real-time Monitoring and Feedback: Continuous, real-time display of critical parameters such as intrauterine temperature, pressure (if balloon-based), and impedance. Allows immediate detection of potential issues (e.g., perforation, inadequate tissue contact) and endures optimal ablation. System automatically terminates energy delivery and provides distinct auditory/visual alarms for abnormal conditions (e.g., uterine perforation/pressure drop, excessive temperature, high impedance, low tissue contact, power surges0. Prevents patient injury and ensures a safe procedure even with varying user experience.
Intuitive user Interface: Touchscreen interface with clear, guided prompts; minimal steps for setup and operation; singl...
Active Contract Opportunity
Notice ID : W81K0025QA150
Related Notice
Department/Ind. Agency : DEPT OF DEFENSE
Sub-tier : DEPT OF THE ARMY
Major Command : US ARMY MEDICAL COMMAND
Office: W40M MRC0 WEST
General Information
Contract Opportunity Type: Sources Sought (Original)
Original Published Date: Jul 17, 2025 08:27 am MDT
Original Response Date: Jul 22, 2025 10:00 am MDT
Inactive Policy: 15 days after response date
Original Inactive Date: Aug 06, 2025
Initiative: None
Classification
Original Set Aside:
Product Service Code: 6515 - MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES
NAICS Code: 339112 - Surgical and Medical Instrument Manufacturing
Place of Performance: Fort Stewart, GA 31314 USA
Documents
Tender Notice